• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

rare Periodic Fever Syndrome - Articles and news items

expanded-novartis

Expanded use for Novartis’ Periodic Fever Syndrome drug after 3 new FDA approvals

Industry news / 27 September 2016 / Niamh Louise Marriott, Digital Content Producer

The expanded use is for Ilaris, a selective, high-affinity, human monoclonal antibody that inhibits Interleukin-1 (IL-1) beta, part of the immune system…

 

Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionWATCH NOW
+ +